Detail Information
Publications
Neuroimaging to assess safety and efficacy of AD therapiesDerek Hill
Medical Imaging Science, UCL and CEO IXICO Ltd, London, UK
Expert Opin Investig Drugs 19:23-6. 2010..While the results of these trials are not yet all available, a recipe for successful deployment of imaging to assess eligibility, safety and efficacy is emerging...
